Tetraspanin CD9 is required for microparticle release from coated-platelets

scientific article published in September 2009

Tetraspanin CD9 is required for microparticle release from coated-platelets is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1080/09537100903096692
P698PubMed publication ID19658001

P2093author name stringGeorge L Dale
Paul Friese
Gyula Remenyi
P2860cites workStructural requirements for the inhibitory action of the CD9 large extracellular domain in sperm/oocyte binding and fusionQ24298326
Platelet activation by CD9 monoclonal antibodies is mediated by the Fc gamma II receptor.Q33404511
Tetraspanins.Q34385526
Functional domains in tetraspanin proteinsQ35063179
COAT plateletsQ35197403
Tetraspanin Proteins Mediate Cellular Penetration, Invasion, and Fusion Events and Define a Novel Type of Membrane MicrodomainQ35564822
Role of FcRgamma and factor XIIIA in coated platelet formationQ35848141
Coated-platelets: an emerging component of the procoagulant responseQ36272167
Antibodies to CD9, a tetraspan transmembrane protein, inhibit canine distemper virus-induced cell-cell fusion but not virus-cell fusionQ39592728
Assessment of in vitro-generated platelet microparticles using a modified flow cytometric strategyQ43660064
Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surfaceQ43863360
Glycoprotein IIb/IIIa inhibitors increase COAT-platelet production in vitroQ44879886
Role of mitochondrial permeability transition pore in coated-platelet formationQ45182830
Quantitation of microparticles released from coated-plateletsQ46651757
Requirement of CD9 on the egg plasma membrane for fertilizationQ48901381
CD9 negatively regulates integrin alphaIIbbeta3 activation and could thus prevent excessive platelet recruitment at sites of vascular injury.Q51812701
CD9 and megakaryocyte differentiation.Q52137869
P433issue6
P304page(s)361-366
P577publication date2009-09-01
P1433published inPlateletsQ1573582
P1476titleTetraspanin CD9 is required for microparticle release from coated-platelets
P478volume20

Reverse relations

cites work (P2860)
Q26748652Extracellular vesicles derived from mesenchymal stromal cells: a therapeutic option in respiratory diseases?
Q37686479Microvesicles as mediators of tissue regeneration
Q50214509Observational retrospective study of vascular modulator changes during treatment in essential thrombocythemia.
Q35632281Overexpression of CD9 correlates with tumor stage and lymph node metastasis in esophageal squamous cell carcinoma
Q38674677Platelet extracellular vesicles induce a pro-inflammatory smooth muscle cell phenotype.
Q37824743Platelet-derived microparticles - an updated perspective
Q38646623Tips and tricks for flow cytometry-based analysis and counting of microparticles.
Q35356235Transcriptomic signatures in whole blood of patients who acquire a chronic inflammatory response syndrome (CIRS) following an exposure to the marine toxin ciguatoxin

Search more.